R$10.84 ($2.07)

+0.10 (+0.93%)

Weekly Expected Move ±3.4%

R$10 R$10 R$11 R$11 R$12

SAO · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 63 · R$2.5B mcap · 39M float · 0.642% daily turnover

Revenue

$1.7B -3.0% ▼

5Y CAGR: +7.6%

Gross Profit

$653M -0.9% ▼

5Y CAGR: +3.3%

Operating Income

$330M -3.5% ▼

5Y CAGR: -3.2%

Net Income

$295M +35.8% ▲

5Y CAGR: +3.0%

EPS (Diluted)

$0.98 -19.7% ▼

5Y CAGR: -7.5%

EBITDA

$394M -3.0% ▼

5Y CAGR: +0.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.4B	$1.4B	$1.4B	$1.8B	$1.7B
YoY Growth	+15.6%	+3.0%	-2.4%	+27.8%	-3.0%
Cost of Revenue	$700M	$739M	$882M	$1.1B	$1.0B
Gross Profit	$666M	$668M	$490M	$659M	$653M
Gross Margin	48.7%	47.5%	35.7%	37.5%	38.3%
R&D Expenses	$52M	$39M	$42M	$30M	$39M
SG&A Expenses	$202M	$175M	$227M	$284M	$288M
Operating Expenses	$256M	$218M	$155M	$349M	$323M
Operating Income	$457M	$450M	$212M	$342M	$330M
Operating Margin	33.4%	32.0%	15.4%	19.5%	19.4%
Interest Expense	$30M	$36M	$38M	$62M	$75M
Income Before Tax	$482M	$469M	$334M	$292M	$388M
Tax Expense	$159M	$108M	$87M	$78M	$92M
Net Income	$325M	$363M	$250M	$217M	$295M
Net Margin	23.8%	25.8%	18.2%	12.4%	17.3%
EPS (Diluted)	$1.81	$2.02	$1.41	$1.22	$0.98
EBITDA	$530M	$523M	$405M	$406M	$394M
Shares Outstanding	179M	179M	178M	178M	300M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$474M	$456M	$373M	$465M	$475M	$389M	$435M	$487M
Cost of Revenue	$286M	$274M	$224M	$278M	$282M	$246M	$263M	$285M
Gross Profit	$182M	$182M	$149M	$187M	$193M	$144M	$172M	$202M
Gross Margin	38.3%	40.0%	40.1%	40.3%	40.6%	36.9%	39.5%	41.5%
R&D Expenses	$8M	$9M	$7M	$9M	$10M	$13M	$10M	$8M
SG&A Expenses	$63M	$78M	$72M	$85M	$90M	$77M	$95M	$101M
Operating Expenses	$71M	$82M	$39M	$83M	$101M	$90M	$86M	$91M
Operating Income	$110M	$101M	$110M	$104M	$92M	$53M	$86M	$111M
Operating Margin	23.3%	22.0%	29.6%	22.3%	19.3%	13.7%	19.7%	22.9%
Interest Expense	$17M	$11M	$16M	$17M	$60M	-$18M	$24M	$21M
Income Before Tax	$95M	$92M	$115M	$91M	$138M	$44M	$52M	$65M
Tax Expense	$26M	$35M	$24M	$28M	$33M	$7M	$16M	$10M
Net Income	$71M	$58M	$91M	$63M	$104M	$36M	$40M	$53M
Net Margin	14.9%	12.7%	24.4%	13.6%	22.0%	9.3%	9.1%	11.0%
EPS (Diluted)	$0.39	$0.33	$0.51	$0.36	$0.59	$0.12	$0.17	$0.23
EBITDA	$131M	$116M	$144M	$127M	$214M	$72M	$104M	$132M
Shares Outstanding	181M	178M	179M	176M	178M	297M	229M	229M

BLAU3.SA SAO